1. Home
  2. INGR vs RGEN Comparison

INGR vs RGEN Comparison

Compare INGR & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ingredion Incorporated

INGR

Ingredion Incorporated

HOLD

Current Price

$111.26

Market Cap

7.1B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$173.31

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INGR
RGEN
Founded
1906
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
8.2B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
INGR
RGEN
Price
$111.26
$173.31
Analyst Decision
Hold
Buy
Analyst Count
7
10
Target Price
$134.57
$174.90
AVG Volume (30 Days)
718.3K
550.6K
Earning Date
02-03-2026
02-19-2026
Dividend Yield
2.97%
N/A
EPS Growth
N/A
N/A
EPS
10.01
0.03
Revenue
$7,262,000,000.00
$707,890,000.00
Revenue This Year
N/A
$17.84
Revenue Next Year
$1.20
$12.44
P/E Ratio
$11.03
$6,658.81
Revenue Growth
N/A
11.74
52 Week Low
$102.31
$102.97
52 Week High
$141.78
$182.52

Technical Indicators

Market Signals
Indicator
INGR
RGEN
Relative Strength Index (RSI) 55.81 65.21
Support Level $108.19 $162.21
Resistance Level $111.83 $167.65
Average True Range (ATR) 1.59 4.82
MACD 0.06 0.47
Stochastic Oscillator 66.00 82.67

Price Performance

Historical Comparison
INGR
RGEN

About INGR Ingredion Incorporated

Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty ingredients that include starch-based texturizers and natural alternative sweeteners such as stevia. Ingredion also sells commodity ingredients that include sweeteners, such as high-fructose corn syrup, and starches, such as those used for sustainable packaging, as well as plant-based proteins.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: